Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/Sezary syndrome

Br J Haematol. 2013 Jul;162(1):130-2. doi: 10.1111/bjh.12320. Epub 2013 Apr 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bexarotene
  • Cyclophosphamide / administration & dosage
  • Humans
  • Mycosis Fungoides / drug therapy*
  • Pentostatin / administration & dosage
  • Sezary Syndrome / drug therapy*
  • Skin Neoplasms / drug therapy*
  • Tetrahydronaphthalenes / administration & dosage
  • Treatment Outcome

Substances

  • Tetrahydronaphthalenes
  • Pentostatin
  • Cyclophosphamide
  • Bexarotene